Corrigendum to "TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43" [Neurobiology of disease Volume 193, April 2024, 106437]

Affiliations

• ¹ Neurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain.
• ² Neurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain; MRC Harwell Institute, Oxfordshire, UK.
• ³ Unidad de Investigación, Hospital Universitario de Canarias, ITB-ULL and CIBERNED, La Laguna, Spain.
• ⁴ Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.
• ⁵ Neurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
• ⁶ Brain Mapping Group, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
• ⁷ Mouse Imaging Centre, The Hospital for Sick Children, Toronto, ON, Canada.
• ⁸ Department of Crystallography and Structural Biology, Institute of Physical Chemistry "Blas Cabrera", CSIC, Madrid, Spain.
• ⁹ MRC Harwell Institute, Oxfordshire, UK; Nucleic Acid Therapy Accelerator (NATA), Harwell Campus, Oxfordshire, UK.
• ¹⁰ Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
• ¹¹ Department of Neuromuscular Diseases, UCL Queen Square Motor Neuron Disease Centre, UCL, Institute of Neurology, London, UK.
• ¹² MRC Harwell Institute, Oxfordshire, UK; MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, UK.
• ¹³ Neurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain; MRC Harwell Institute, Oxfordshire, UK. Electronic address: [email protected].